Pioneering technologies that create novel antibody therapeutics to treat cancer and other serious diseases.
Research
Innovation
Discover how ÐǺ£ÆåÅÆ makes a positive impact for patients, communities, employees and the environment
Corporate and financial resources for ÐǺ£ÆåÅÆ investors, potential shareholders and analysts
Resources
Financials
Stock Information
Governance
ÐǺ£ÆåÅÆ
ÐǺ£ÆåÅÆ ÐǺ£ÆåÅÆ
Rooted in science and inspired by patients, we are committed to improving lives through innovative and differentiated antibody therapeutics.
This is who we are. Our antibody therapeutics aim to transform the lives of people with cancer and other serious diseases. For our teams, this is the strongest possible motivation to come to work every day. It's what drives us to keep innovating.
Antibody science
Our pioneering technologies create next-generation therapeutic antibodies to treat cancer and other serious diseases.
ÐǺ£ÆåÅÆ
Our history has been powered by our dedication to antibody-based therapeutics. It is this same spirit that will guide us into the future.
We aspire to transform the treatment of cancer and other serious diseases through the development of next-generation antibody therapies, and I'm proud to say that ÐǺ£ÆåÅÆ is well on track to deliver on that vision.
Jan G. J. van de Winkel, Ph.D
President and CEO
